| INTRODUCTION
Prostate cancer (PCa) is the second most common cancer in men and the fourth most common tumor type worldwide. 1 PCa remains a high burden in the current healthcare system, especially once it develops into castration resistant PCa (CRPC) Most preclinical studies of PCa depend heavily on immortalized cancer cell lines, which are grown in culture dishes as a two-dimensional model. These models do not recapitulate the complex architecture of tumors nor the important interaction between tumor cells and their microenvironment. 2 They do therefore not always accurately predict treatment efficacy and these limitations could lead to a failure when transitioning a new drug from the bench to the clinic.
As an alternative, ex vivo culturing of tumor slices represent a solid model system for drug sensitivity testing due to its relatively short generation time and reflection of the tumor microenvironment. [3] [4] [5] [6] [7] For example, several studies have shown that breast tumor tissue slices can be used to assess chemotherapy response in the context of personalized medicine. [8] [9] [10] In recent years, efforts have been undertaken to establish such strategies to generate primary cultures from human prostate tumors and innovative complex culture systems.
Unfortunately, the establishment of primary PCa organotypic cultures proved to be extremely challenging due to the slowgrowing characteristics of the PCa cells; basal epithelial cells proliferate faster than tumor cells and often outgrow them during prolonged culture. [11] [12] [13] To allow testing of therapy responses in different genetic and functional backgrounds of PCa, we set out to develop an optimized tissue slice culture system. We used well-established patient-derived xenograft (PDXs) models as a source for the tissue slices [14] [15] [16] and show that our tissue slice culture system provides treatment outcome that recapitulates responses previously found in vivo.
| MATERIALS AND METHODS

| Reagents
Reagents were purchased from Sigma-Aldrich (Darmstadt, Germany) unless otherwise specified.
| Collection of PDX tumor tissue
PDXs of PCa (PC295, PC339, and PC310) were established by van Weerden et al 14 and were routinely passaged by subcutaneous grafting of small fragments onto both shoulders of intact male athymic NMRI nu/nu mice (Taconic Biosciences, Cologne, Germany). Characteristics of the different PDXs are summarized in Table 1 . Fresh PDX tumors with volume of 500-1000 mm 3 were obtained. After removal from mice, the tumors were kept on ice in Dulbecco's Modified Eagle Medium (DMEM; Lonza, Verviers Sprl, Belgium).
| Tissue slice and culture
Tumor slices were generated using a vibratome (Leica VT1200S; Leica, Nussloch, Germany) with a thickness set at 300 µm, vibration amplitude at 3.0 mm and slicing speed at 0.6 mm/sec. Slices were either submerged directly in 3 mL culture medium or placed on Falcon 40 µm Cell Strainers or Millicell 0.4 µm Cell inserts (Merck Millipore, Bedford, UK) and then cultured in 3 mL culture medium in six well plates. The culture media that were tested for quality assessment are summarized in Table 2 . Slices were put in culture within 3 h after the tumor was removed from the mouse. Culturing was performed at 5% CO 2 at 37°C and at atmospheric oxygen levels. Culture plates were Figure 1 ).
| Ex vivo antiandrogen and PARP-1 inhibitor treatment
To test the response of antiandrogen and poly (ADP-ribose) 
| Hematoxylin and eosin staining
Histological tumor architecture was examined by hematoxylin and eosin (H&E) staining. Briefly, sections were deparaffinized in xylene followed by rehydration in graded alcohols. They were then stained with hematoxylin for 1 min, rinsed with tap water, stained with eosin for 1 min, and rinsed again with tap water. The slides were then dehydrated with increasing concentration of ethanol successively followed by xylene and mounted with entellan.
| Immunohistochemical and fluorescent procedures
Sections were deparaffinized in xylene followed by rehydration in graded alcohols. Antigen retrieval was performed with target retrieval buffer (Dako, Glostrup, Denmark). For diaminobenzidine (DAB) staining, endogenous peroxidase activity was blocked by using 3% hydrogen peroxide solution in methanol at RT for 
| TUNEL assay
Terminal deoxynucleotidyl transferase dUTP nick end-labeling (TU-NEL) assay was performed using In Situ Cell Death Detection Kit (Roche Life Sciences, Penzberg, Germany) according to instruction of the manufacturer.
| Medium prostate-specific antigen (PSA) measurement
Tumor slices culture medium (1 mL) was collected daily for PSA measurement. The PSA concentration was measured using a PSA enzyme-linked immunosorbent assay (ELISA) kit (Abnova, Taipei City, Taiwan) according to the manufacturer instructions. The accumulated PSA concentration in the culture medium was calculated using the following formula (which corrects for medium removal each day):
2.10 | Image acquisition image was created using a modified triangle-thresholding method in which black areas completely enclosed by white areas were filled. 19 Next, a morphological dilation was applied using a circular structuring element with a radius of three pixels. All pixels that still had a value of one then constitute a newly formed gradient mask image. 
| Statistical analysis
Results are expressed as the mean ± SEM or median ± quartile in bar graph. Mann-Whitney test was used to analyze the differences between two groups. Statistical analysis and generation of graphs was performed using Graphpad Prism 6.0 (La Jolla, CA). P < 0.05 was considered statistically significant. *P < 0.05, **P < 0.01, ***P < 0.001.
3 | RESULTS
| Culture condition selection
To establish the most optimal culture method for preservation of PCa tissue slice viability we developed an optimized culture system and compared it to previously reported systems. 20, 21 Tumor slices from PC295, PC339, and PC310 PCa PDXs were generated using a vibratome and these slices were cultured in prostate growth medium (Figure 2A and Figure S1 ). Moreover, in contrast what was observed previously using inserts, we did not observe a viability gradient nor loco-regional changes in morphology. 15 The thymidine analog EdU was used as a real-time proliferation marker to assess tissue viability. We tested the reliability of our newly 
| Optimal medium selection
The culture medium composition has vital impact on the viability of tissue slices. To select the optimal medium, we therefore tested four different culture media that have been reported previously for primary prostate cell or tumor culturing (Table 2) . 20, 21, [23] [24] [25] Tissue morphology analysis showed that Prostate Growth Medium (PGM) 24 and aDMEM/ F12 K outperformed the other media tested ( Figure S3 ). We compared incubation of tissue slices from PC295 and PC339 to determine which medium preserved tumor cell viability most optimally. Average tissue proliferation remained constant for PC339 (average 10%) up to 6 days of culturing in both media while proliferation of PC295 reduced over time in both media (initial 10.7%, and 2.5% and 3.6% in PGM and aDMEM/F12 K, respectively after 6 days). There was no significant difference in performance between the two culture media for both PDXs ( Figure 3A ).
PGM constitutes 2% fetal calf serum (FCS) and is supplemented
with the synthetic androgen R1881 (0.1 nM), while aDMEM/F12 K devoid of FCS and does not contain R1881. The clear benefit of using serum-free medium led us to test the impact of addition of the same concentration of R1881 to the aDMEM/F12 K medium. Three tumors of PC295 and PC339 each were cultured under optimal conditions in aDMEM/F12 K or in aDMEM/F12 K supplemented with R1881. We found a significantly higher proliferation rate of the PC295 slices cultured in aDMEM/F12 K supplemented with R1881 compared to aDMEM/F12 K without R1881 (1.9 fold at day 6) ( Figure 3B ). As expected, addition of R1881 did not affect proliferation rates of androgen independent PC339 slices ( Figure 3B ). Some increase in apoptosis was observed in PC339, while PC295 maintained its low apoptosis levels for up to 6 days of ex vivo culturing ( Figure 3C ).
To further assess tissue maintenance, we measured AR expression, a major characteristic of androgen dependent prostate tumors.
Immunohistochemical stainings showed that AR expression was largely maintained during ex vivo culturing of PC295 slices, with a small but significant decrease of AR expression in slices cultured at 6 days in either PGM or aDMEM/F12 K ( Figures 4A and 4B ). The addition of R1881 to aDMEM/F12 K medium preserved AR levels up to 6 days of incubation ( Figures 4C and 4D ).
Because androgen stimulates PSA secretion from PCa cells, we measured PSA levels in the culture media. Medium from PC295 tumor slices was collected for up to 6 days and PSA accumulation was monitored. After normalization to initial PSA levels, we observed a continuous increase in PSA for up to 6 days in cultures supplemented with R1881 while slices cultured in aDMEM/F12 K without R1881
showed a stabilization of PSA levels ( Figure 4E ). Altogether, we concluded that serum-free aDMEM/F12 K plus R1881 is the optimal medium for further use showing maintenance of tissue slice morphology, viability, and AR-functionality.
| Enzalutamide treatment of tissue slices
In order to validate the accuracy of the tissue slice system to reflect clinical responses to relevant therapies, we investigated the response to enzalutamide, a second generation antiandrogen which is currently being tested in a randomized phase III trial. 
| Olaparib treatment of tissue slices
Mutations in the DNA repair gene BRCA2 have been identified in PCa patients, and previous studies have shown that these specific patients benefit from treatment with olaparib, an inhibitor of poly[adenosine diphosphate (ADP)-ribose] polymerase-1 (PARP-1). 27 We therefore assessed the response to olaparib treatment in PC295 (BRCA2 wildtype) and PC310 (BRCA2 mutated) tumors. A significant drop in the fraction of S-phase cells was observed for both PC295 and PC310 tumor slices (decreased by a factor of 2.65 and 10, respectively) when treated with olaparib for 6 days, with a more pronounced reduction in PSA measurement revealed reduced PSA levels of both PC295 and PC310 slices ( Figure 6D ). In conclusion, both BRCA2 deficient and proficient tumors are hampered by olaparib treatment, but only BRCA2 deficiency causes induction of apoptotic cell death.
| DISCUSSION
We have established an optimized ex vivo tissue slice culture system using PCa PDXs. Under optimal culture conditions, tumor morphology, cell proliferation, and prostatic characteristics are preserved for up to 6 days with minimal induction of cell death. Furthermore, we showed that this system is suitable for PCa drug testing: we observed responses to enzalutamide in androgen dependent tumor slices as well as to olaparib in BRCA2 mutant tumor slices that reflect in vivo therapy
responses.
An ex vivo tumor culture system should maintain cancer characteristics and tumor proliferating capacity during ex vivo culturing to allow reliable therapy response evaluation. Since the 1970s, various studies have been described that aim to establish an ex vivo culture system for PCa tumors. This has resulted in the development of different tumor culture methods, ranging from direct culturing of 1-2 mm 3 human tissue samples in medium to more recently developed techniques to culture precision cut tissue slices on various scaffolds and supporting filters, such as gelatin, collagen sponges, or titanium mesh inserts. 21, 23, 28, 29 As reported in these studies, maintenance of prostate or PCa tissue slices for a week could for intensive technical studies. In order to reduce slice heterogeneity from the same tumor as much as possible, slices were consecutive allocated to each experimental treatment. We were able to keep longevity of tumor slices by using serum-free aDMEM/F12 K medium with the addition of synthetic androgen up to 6 days. This medium shares many similar ingredients with medium PFMR-4A which was reported previously for successful maintenance of benign and malignant prostate tissue slices for 5 days. 21 Serum-free medium allows more precise evaluations of cellular function and better control over physiological responsiveness.
One of the strengths of this study is the use of EdU incorporation to assess cell proliferation, allowing real time measurement of DNA synthesis during replication. We believe that this is a more reliable way to measure early treatment effects compared to the commonly used Ki67 marker. Ki67 protein is present in all cycling cells, even for several days after cells have ceased to proliferate. 42 Indeed, we observed a disparity between EdU ratio and Ki67 expression: after 6 days culturing EdU ratio dropped significantly while Ki67 only showed a slight reduction ( Figure S5 ). In the majority of tumor slices from all three PDXs tested, we observed an increase of proliferation after one day of incubation, followed by maintenance of proliferation for PC339
and PC310, or only a slight decrease of proliferation in case of PC295 compared to day 0. The first-day proliferation boost might be a result of the availability of a high level of nutrients and oxygen. The initial high TUNEL level in PC339 slices is most likely due to a higher level of necrosis in the original tumor sample, since TUNEL assay is unable to distinguish necrosis and apoptosis. 43 We observed a marginal effect of androgen deprivation on tumor slice viability in androgen responsive PDX tissue slices. This might be caused by the presence of endogenous androgen maintained in the tumor slices and which is gradually released into the medium during culturing. Thus, endogenously present androgen can be used to maintain activation of AR signaling and proliferation for a few days. that that CRPC patients with somatic loss and germline mutation of BRCA2 respond well to olaparib. 27 Similar was reported by Beshiri et al 46 for PCa PDX organoid cultures in which BRCA2 deficiency correlates with olaparib sensitivity. PARP-1 inhibitors with high PARP trapping potency, such as olaparib, can yield intense replication stress, 47, 48 which can explain the decrease of fraction of S-phase cells in the BRCA2 wild-type PC295 slices.
So far, several publications have suggested that tumor tissue slice culture can be utilized to predict drug response in breast cancer [8] [9] [10] and monitor cytotoxic drug effects in liver, intestine, and lung. [49] [50] [51] We have established dedicated tissue slice system for PCa that shows robust and specific antiandrogen and PARP-1 inhibition treatment effects and that can be extended to testing of novel compounds relevant to PCa.
| CONCLUSIONS
The faithful retention of tissue structure and function in our ex vivo culture system offers an opportunity to evaluate PCa response to therapeutic compounds making it an ideal system for low to medium throughput testing in drug discovery.
